Andrew Mardis (@bamardis) profile picture

Husband, father, medical science liaison, former heart failure/transplant pharmacist

Columbia, SC
Joined September 2014
Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)Photo by Andrew Mardis (@bamardis)
“After more than 40 years together, I know when ‘I’m fine’ doesn’t necessarily mean he’s fine.” Liz on being a care partner to her husband Art, who lives with hereditary ATTR. Learn more about Liz's story she shared with us for #CaregiverAwarenessMonth: bit.ly/4sQP49Z
1
1
222
Andrew Mardis retweeted
if anything, considering the level of dialogue, acting and psychological complexity of the characters, it might be underrated
we need to start a conversation about how succession is overrated and it’s nowhere near the level of the all-time greats
32
1,075
101
7,899
262,227
For Gesna, her ATTR-CM diagnosis brought clarity to the symptoms that had impacted her family for generations. This #AmyloidosisAwarenessMonth, she's sharing her experience to encourage earlier conversations around family health history and greater awareness of hereditary ATTR (#ATTRv), especially in the African American community, where certain genetic variants may be more prevalent but remain underrecognized. By sharing her story, Gesna hopes to empower more people to ask questions, understand their risk, and take proactive steps toward earlier testing and care.
1
301
Andrew Mardis retweeted
1/43 Welcome to this MedX CME on transthyretin amyloid cardiomyopathy (ATTR-CM), including updates in treatment from ACC25, with cardiologist Michelle Kittleson, MD, PhD. Earn credit: link.med-iq.com/57jSxO
1
5
21
64,249
Excited to announce the dosing of our first participant in ACT-EARLY, the first-ever primary prevention study for ATTR testing if prophylactic treatment of asymptomatic carriers with acoramidis can delay or prevent disease onset. Learn more: bit.ly/4jPqdhn
3
1
12
9,815
In the April #BPS Leadership Blog, Andrew Mardis, Medical Science Liaison, highlights the value of board certification throughout his career, even as he transitioned away from direct patient care. Read his blog here: bpsweb.org/2025/04/28/mainta…
1
2
186
This year at @ACCintouch, we met with leaders in cardiology and learned about innovative developments for patients with heart conditions like ATTR-CM. We also had the opportunity to share findings from ATTRibute-CM, our Phase 3 clinical trial for ATTR-CM. #ACC25
2
7
415
Join us this year at @ACCintouch 2025 in Chicago! We’ll be providing new updates on our TTR stabilizer for ATTR-CM as well as supporting an industry expert theater with @Medscape. Learn more: investor.bridgebio.com/press… #ACC25
1
10
387
We’re excited to announce that data from the ATTRibute-CM Phase 3 study will be presented at the @ACCinTouch 2025. The data on cardiovascular outcomes in variant and wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) patients will be featured in a flat board poster presentation. We will also share five posters and two moderated posters on ATTR-CM. Learn more: bit.ly/4kTBP3Y #ACC2025
1
2
16
544
📢 Fellowship Opportunity! Apply Now! 🏥 The Medical University of South Carolina’s Division of Cardiology is now accepting applications for a one-year, non-ACGME Amyloidosis Fellowship. 🔬 Gain specialized clinical & research training in amyloidosis and advance your expertise!
1
5
18
3,024
🚨 Early diagnosis = better outcomes! Learn to spot clinical signs of ATTR-CM, use biomarkers for precision care, and implement evidence-based management strategies. 🏥 #ACC25 🔗 Secure your spot now: ms.spr.ly/6013qEVtv @SarswatNitasha
3
4
5
1,243
It is #AmyloidosisAwarenessMonth #DYK ATTR can impact individuals at any age? Follow along this month as we work to #IlluminateATTR, today and all year long.
2
10
502
ASNC Masterclass: Cardiac Amyloidosis Join Dr. Frederick Ruberg & Dr. Andrew Staron of @BU_Amyloidosis for an expert-led session on the latest in cardiac amyloidosis imaging & management! Learn from top experts in the field!#ASNC 📅 March 7-9, 2025 💻 Virtual Event – Open to All!
5
16
827
Andrew Mardis retweeted
Cooper Manning shares his approach to parenting Arch in the era of NIL and the evolving landscape of college football.
42
209
63
2,587
467,290
Andrew Mardis retweeted
Happening 12/3! HFSA Education Partner Program: Don't Fail Them Now: Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis. Discover More >> bit.ly/3Z7JAtc
10
11
668
Join us at #AHA24! We’ll be presenting a featured science presentation on our outcomes data through 42 months from the open-label extension of ATTRibute-CM, our Phase 3 Study of acoramidis for ATTR-CM & three moderated digital poster presentations. bit.ly/4eYVDPW
1
1
11
1,585
GAMEDAY LET’S GO
6
136
1,654
57,597
In honor of World Amyloidosis Day, we hope to raise awareness about how people are impacted by amyloidosis. We believe that by providing education about the condition, we will help eliminate delays in diagnostics for patients. Learn about how to support the amyloidosis community: bit.ly/3PPUvnX #WorldAmyloidosisDay
1
5
371
🚀 Elevate your expertise in ATTR-CM at the 3rd International Congress on ATTR Amyloidosis. Interactive, 🧠 expert-led session with @maz_hanna, @BrettSperryMD, @NotNoninvasive and @Ron_Witteles. Click here now: ms.spr.ly/6013mmT3B #ICAAlive24
6
14
1,780
We’re thrilled to share our outcomes data from our long-term open-label extension of ATTRibute-CM, our Phase 3 study of acoramidis in ATTR-CM, in a featured science oral presentation at the 2024 @American_Heart Scientific Sessions. Learn more: bit.ly/4eNw9V8
3
1
12
856